Liberty Wealth Management LLC Gossamer Bio, Inc. Transaction History

Liberty Wealth Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$10.12 - $14.07 $20,240 - $28,140	-2,000 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$8.0 - $9.75 $113,920 - $138,840	-14,240 Reduced 87.68%	2,000 $16,000
Q2 2021 Aug 13, 2021	BUY	$8.0 - $9.75 $113,920 - $138,840	14,240 Added 712.0%	16,240 $2 Million
Q4 2020 Feb 09, 2021	BUY	$8.3 - $13.59 $16,600 - $27,180	2,000 New	2,000 $20,000

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $66.7M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Liberty Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Liberty Wealth Management LLC with notifications on news.